Fast, efficient, quality results.
We want to help you get your projects out of discovery and into late preclinical evaluation as fast as possible. To accomplish this we focus on efficiency through the parallel use of in silico predictions and high-throughput in vitro technologies, and on quality by incorporating, early on, as much developability data as possible to reduce downstream development risks.
Our Drug Discovery Services Include:
- Lead Generation: Enhanced Rational Drug Design and Fast-Track Hit Validation
- Multi-Parametric Lead Optimization: Better Candidates in Less Time
- Explora ADMET and PK: Early Developability Evaluation
Services: Focused on Drug Discovery
Essential characteristics of our drug discovery services include:
- extensive use of in silico prediction to increase efficiency
- high-throughput parallel synthesis combined with classical iterative chemistry to explore the full range of chemical possibilities
- important downstream developability assays, such as biological membrane permeability, metabolic stability and biotransformation studies, P450 interactions, in vitro cytotoxicity, hERG binding, protein binding, physico-chemical parameters’ determination, and more
- preliminary PK parameters determination
- goal oriented attitude: our clients and partners must succeed for us to succeed!
- no hype, propaganda or surprises: just quality results!